Canada Markets closed

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.8500+0.0400 (+2.21%)
At close: 04:00PM EST
1.8000 -0.05 (-2.70%)
After hours: 07:48PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.8100
Open1.8400
Bid1.7900 x 41800
Ask1.8600 x 40700
Day's Range1.7620 - 1.9500
52 Week Range1.0400 - 3.8200
Volume13,251,884
Avg. Volume4,247,021
Market Cap732.278M
Beta (5Y Monthly)N/A
PE Ratio (TTM)925.00
EPS (TTM)0.0020
Earnings DateOct 27, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.33
  • GlobeNewswire

    Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand

    Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Medsafe in New Zealand has granted approval to VAZKEPA (icosapent ethyl) to reduce the risk of cardiovascular (CV) events in adult statin-treated patients with high CV risk with elevated triglycerides. Cardiovascular disease is a significant health issue for people li

  • GlobeNewswire

    Amarin to Present at SVB Securities Global Biopharma Conference

    DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the SVB Securities Global Biopharma Conference. SVB Securities Global Biopharma Conference (February 13-16th, 2023; Virtual) Date/Time: February 14, 2023 10:40 a.m. ET Webcast: https://wsw.com/webcast/svb8/register.aspx?conf=svb8&page=amrn&url=https://wsw.com/webcast/svb8/am

  • Zacks

    Amarin Corporation (AMRN) Down 13% in One Week: Here's Why

    Shares of Amarin Corporation (AMRN) fell last week as the company's largest shareholder pressurizes the company to make changes to its board of directors.